Short answer
Zoetis (ZTS) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $2.3B (up 1.9% year over year) with net income of $601M.
Q1 2026 key financials · XBRL
- Revenue
- $2.3B
- +1.9% YoY
- Net income
- $601M
- −4.8% YoY
- EPS (diluted)
- $1.42
- +0.7% YoY
Source: XBRL data from the Zoetis (ZTS) Q1 2026 10-Q on SEC EDGAR. USD.
Zoetis Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $2.262B, up $64M or 3% YoY; foreign exchange contributed 4%
- Net income $601M vs $602M; adjusted net income $646M vs $633M
- International segment sales benefited 2.5%-3.5% from accelerated fourth-quarter 2025 timing
- Approximately 47% of revenue denominated in foreign currencies; tariffs may increase product costs
- December 2025 international sales timing shifted certain orders into first-quarter 2026
Risk Factors
- No Risk Factors section provided, preventing identification of new or changed risks versus the 10-K
- $1.8B remaining under the $6B share-repurchase authorization as of March 31, 2026
- $1.783B of convertible-note proceeds used for repurchases, including $248M initially and $1.535B subsequently
- 0.250% convertible senior notes issued December 18, 2025, creating new debt-servicing and dilution exposure
- KPMG preferability letter filed for a change in accounting principle, creating additional financial-reporting compliance exposure
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Zoetis quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.